Home > Insider Trading > Filing (0001019687-10-001406)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882291	Aethlon Medical Inc	AEMD.OB	Laboratory Analytical Instruments (3826)	133632859

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1284599	G Edward Broenniman	8910 University Center Lane, #660 San Diego CA 92122		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2010-03-31	11,000	$0.37	371,374	No	4	S	Direct
Common Stock	Disposition	2010-04-01	11,400	$0.37	359,974	No	4	S	Direct
Common Stock	Disposition	2010-04-05	11,500	$0.35	348,474	No	4	S	Direct
Common Stock	Disposition	2010-04-06	11,900	$0.35	336,574	No	4	S	Direct
Common Stock	Disposition	2010-04-07	12,000	$0.35	324,574	No	4	S	Direct
Common Stock	Disposition	2010-04-08	12,500	$0.34	312,074	No	4	S	Direct
Common Stock	Disposition	2010-04-09	12,500	$0.33	299,574	No	4	S	Direct
Common Stock	Disposition	2010-04-12	12,500	$0.34	287,074	No	4	S	Direct
Common Stock	Disposition	2010-04-13	4,900	$0.34	282,174	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

THIS CONCLUDES THE SALE OF THE 200,000 SHARES COVERED BY THE PLAN DESCRIBED BELOW IN FOOTNOTE 2 FOR SALE THROUGH MARCH 14, 2011.
The shares of common stock were sold by Mr. Broenniman pursuant to a 10b5-1 selling plan providing for the sale of up to 200,000 shares of the issuer's common stock between March 15, 2010 and March 14, 2011. The plan provides for sales of the shares at a price of no less than $0.30 per share, at a rate of no more than 5% of the average trading volume in the issuer's common stock for the 30-day period preceding the sale, as reported on dailyfinance.com; provided that such sales may not exceed 1% of the outstanding share balance during any 90-day period.
In addition to the currently outstanding shares of common stock owned by Mr. Broenniman and reported here, Mr. Broenniman also beneficially owns the shares of common stock underlying the following stock options: options to purchase 2,500 shares of common stock at $3.75 per share; options to purchase 3,000 shares of common stock at $1.78 per share; options to purchase 514,550 shares of common stock at $0.38 per share; and options to purchase 500,000 shares of common stock at $0.41 per share.
Includes 33,885 shares of common stock owned by Linda Broenniman, the spouse of Edward Broenniman, and 246,300 shares jointly owned by Edward and Linda Broenniman.